Q1 2024 American Well Corp Earnings Call Transcript
Key Points
- American Well Corp reported a strong start to the year with significant new customer wins and a positive revenue mix, indicating robust market acceptance of their platform.
- The company has successfully expanded into the government sector, specifically modernizing the military health system, demonstrating scalability and enhanced cybersecurity capabilities.
- American Well Corp is making strides in cost reduction, aiming for a significantly lower cost structure as reflected in forward guidance, which supports future profitability.
- The company's technology and platform, especially the Converged platform, are well-received by clients, showing high user satisfaction scores and NPS ratings, which drives long-term customer relationships.
- American Well Corp has a strong balance sheet, which is expected to support the company's operations and growth well beyond the projected timeline to achieve profitability in 2026.
- There was a slight decline in total visits in Q1 2024 compared to the previous year, influenced by external factors such as the Change Healthcare security breach and disruptions from large client migrations.
- Revenue for Q1 2024 showed a decrease of 7% year-over-year, primarily due to declines in subscription revenue related to legacy platform usage.
- The company is still operating at a loss, with a reported adjusted EBITDA of negative $45.7 million for the quarter, although this is part of a controlled path towards future profitability.
- American Well Corp faces challenges in the highly competitive digital health market, requiring continuous innovation and adaptation to maintain and grow its market share.
- While the company is reducing its R&D spend, this necessary cost-cutting could potentially slow down the pace of innovation compared to competitors who may continue to invest heavily in R&D.
Good afternoon. My name is Brianna, and I will be your conference operator today. At this time, I would like to welcome everyone to the Amwell Q1 2024 earnings call. (Operator Instructions) Thank you. I would now like to hand the call over to Sue Dooley, Head of Investor Relations with Amwell. You may begin.
Hello, everyone. Welcome to Amwell conference call to discuss our first fiscal quarter of 2024. This is Sue Dooley of Amwell Investor Relations. And joining me today are Amwell 's Chairman and CEO, Dr. Ido Schoenberg and RobShepardson, our CFO.
Earlier today, we distributed a press release detailing our announcement. Our earnings release is posted on our website at investor dot analog.com and is also available through normal new sources. This conference call is being webcast live on the IR page of our website, where a replay will be archived before we begin our prepared remarks, I'd like to take this opportunity to remind you that during the course of the call, we will make forward
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
